|
KIAA1109 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.74440034534018E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.25799983950048E-10 |
| Normal-vs-Stage2 |
1.823650E-04 |
| Normal-vs-Stage3 |
3.90720000797984E-09 |
| Normal-vs-Stage4 |
2.16269999686602E-08 |
| Stage1-vs-Stage2 |
6.023000E-01 |
| Stage1-vs-Stage3 |
7.933600E-02 |
| Stage1-vs-Stage4 |
5.747700E-02 |
| Stage2-vs-Stage3 |
8.784200E-02 |
| Stage2-vs-Stage4 |
4.468100E-02 |
| Stage3-vs-Stage4 |
4.578600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.10119946284249E-10 |
| Normal-vs-AfricanAmerican |
2.44790000492046E-08 |
| Normal-vs-Asian |
3.66630000000479E-05 |
| Caucasian-vs-AfricanAmerican |
9.510800E-01 |
| Caucasian-vs-Asian |
3.956600E-01 |
| AfricanAmerican-vs-Asian |
3.951200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.72819602651498E-11 |
| Normal-vs-Female |
9.09060000053863E-07 |
| Male-vs-Female |
9.655700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.84450000051406E-07 |
| Normal-vs-Extreme_Weight |
1.60930047066188E-10 |
| Normal-vs-Obese |
9.55890000486903E-08 |
| Normal-vs-Extreme_Obese |
1.368690E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.701400E-01 |
| Normal_Weight-vs-Obese |
6.235000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.254800E-01 |
| Extreme_Weight-vs-Obese |
2.867800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.344000E-01 |
| Obese-vs-Extreme_Obese |
9.552200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.91599999994119E-07 |
| Normal-vs-Age(41-60Yrs) |
1.52069999925786E-08 |
| Normal-vs-Age(61-80Yrs) |
1.63119961982261E-10 |
| Normal-vs-Age(81-100Yrs) |
2.98430000000849E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.336400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.960600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.710800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.262800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.550400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.432600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.97479999020089E-09 |
| Normal-VS-Type2 PRCC |
2.83030265890716E-11 |
| Normal-VS-KIRP CIMP |
3.19289999994865E-06 |
| Normal-VS-Unclassified PRCC |
2.234000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.347600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.296400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.866400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.763800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.726400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.472560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.28489457857017E-11 |
| Normal-vs-N1 |
1.07359998668954E-09 |
| Normal-vs-N2 |
8.953600E-04 |
| N0-vs-N1 |
5.628000E-01 |
| N0-vs-N2 |
7.622600E-01 |
| N1-vs-N2 |
9.732600E-01 |
|
|
